carbamazepine-10,11-epoxide

Modify Date: 2024-01-02 21:25:05

carbamazepine-10,11-epoxide structure	Common Name	carbamazepine-10,11-epoxide
	CAS Number	36507-30-9	Molecular Weight	252.26800
	Density	1.377g/cm3	Boiling Point	390.2ºC at 760mmHg
	Molecular Formula	C₁₅H₁₂N₂O₂	Melting Point	204-206ºC
	MSDS	Chinese USA	Flash Point	189.8ºC
	Symbol	GHS09	Signal Word	Danger

Use of carbamazepine-10,11-epoxide

Carbamazepine 10,11-epoxide is an orally active metabolite of Carbamazepine (HY-B0246). Carbamazepine has anticonvulsant effect. Carbamazepine can be used for the research of seizures[1].

Name	carbamazepine-10,11-epoxide
Synonym	More Synonyms

Description	Carbamazepine 10,11-epoxide is an orally active metabolite of Carbamazepine (HY-B0246). Carbamazepine has anticonvulsant effect. Carbamazepine can be used for the research of seizures[1].
Related Catalog	Research Areas >> Neurological Disease

Density	1.377g/cm3
Boiling Point	390.2ºC at 760mmHg
Melting Point	204-206ºC
Molecular Formula	C₁₅H₁₂N₂O₂
Molecular Weight	252.26800
Flash Point	189.8ºC
Exact Mass	252.09000
PSA	58.86000
LogP	3.79470
Index of Refraction	1.686
Storage condition	−20°C

carbamazepine-10,11-epoxide MSDS(Chinese)

CHEMICAL IDENTIFICATION

RTECS NUMBER :: HQ4430000

CHEMICAL NAME :: 6H-Dibenz(b,f)oxiren(d)azepine-6-carboxamide, 1a,10b-dihydro-

CAS REGISTRY NUMBER :: 36507-30-9

LAST UPDATED :: 199706

DATA ITEMS CITED :: 5

MOLECULAR FORMULA :: C15-H12-N2-O2

MOLECULAR WEIGHT :: 252.29

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 420 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: TAKHAA Takeda Kenkyusho Ho. Journal of the Takeda Research Laboratories. (Takeda Yakuhin Kogyo K.K., 2-17-85 Jusohon-machi, Yodogawa-ku, Osaka 532, Japan) V.29- 1970- Volume(issue)/page/year: 37,12,1978 ** REPRODUCTIVE DATA **

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

DOSE :: 9600 mg/kg

SEX/DURATION :: female 2 week(s) pre-mating female 1-18 day(s) after conception

TOXIC EFFECTS :: Reproductive - Specific Developmental Abnormalities - musculoskeletal system

REFERENCE :: JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 279,1237,1996

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

DOSE :: 19200 mg/kg

SEX/DURATION :: female 2 week(s) pre-mating female 1-18 day(s) after conception

TOXIC EFFECTS :: Reproductive - Specific Developmental Abnormalities - other developmental abnormalities

REFERENCE :: JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 279,1237,1996

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

DOSE :: 32 gm/kg

SEX/DURATION :: female 2 week(s) pre-mating female 1-18 day(s) after conception

TOXIC EFFECTS :: Reproductive - Maternal Effects - other effects Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)

REFERENCE :: JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 279,1237,1996

Symbol	GHS09
Signal Word	Danger
Hazard Statements	H411
Precautionary Statements	P273
Hazard Codes	Xn: Harmful;
Risk Phrases	R22;R36/37/38
Safety Phrases	26-36
RIDADR	UN 2811
WGK Germany	3
RTECS	HQ4430000
Packaging Group	III
Hazard Class	6.1(b)
HS Code	2933990090

Carbamazepine

CAS#:298-46-4

~88%

carbamazepine-1...

CAS#:36507-30-9

Literature: KANDULA, Mahesh Patent: WO2013/167985 A1, 2013 ; Location in patent: Paragraph 00100; 00101 ;

Carbamazepine

CAS#:298-46-4

carbamazepine-1...

CAS#:36507-30-9

10,11-Dihydro-1...

CAS#:35079-97-1

Literature: Applied Catalysis A: General, , vol. 408, # 1-2 p. 25 - 30

Carbamazepine

CAS#:298-46-4

carbamazepine-1...

CAS#:36507-30-9

carbamazepine c...

CAS#:52618-28-7

Literature: Journal of Pharmacy and Pharmacology, , vol. 36, # 12 p. 843 - 844

Precursor 1
CAS#:298-46-4 Carbamazepine
DownStream 6
CAS#:28721-07-5 Oxcarbazepine CAS#:104746-04-5 Eslicarbazepine CAS#:29331-92-8 Licarbazepine CAS#:68011-71-2 9-hydroxymethyl...
CAS#:885-23-4 9-Acridinecarbo... CAS#:106680-74-4 9-formyl-10-car...

HS Code	2933990090
Summary	2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Influence of CYP3A4 induction/inhibition on the pharmacokinetics of vilazodone in healthy subjects.

Clin. Ther. 36(11) , 1638-49, (2014)

Vilazodone is a serotonin reuptake inhibitor and 5-HT1A partial agonist approved for the treatment of major depressive disorder in adults. Vilazodone seems to be metabolized primarily by the cytochrom...

Evaluation of the potential for pharmacokinetic drug-drug interaction between armodafinil and carbamazepine in healthy adults.

Clin. Ther. 37(2) , 325-37, (2015)

Polypharmacy is common in psychiatry practice and can lead to an increased risk of drug interactions. Armodafinil, a wakefulness-promoting agent, has been studied as adjunctive therapy for the treatme...

Successful treatment of carbamazepine poisoning with hemodialysis: a case report and review of the literature.

Hemodial. Int. 15(3) , 407-11, (2011)

A 48-year-old man was brought to the emergency room after ingesting an unknown amount of carbamazepine. He was unconscious and not responding to the noxious stimuli. He was intubated and was placed on...

1a,10b-Dihydro-6H-dibenzo(b,f)oxireno[d]azepine-6-carboxamide

Carbamazepine 10,11-Epoxide

Carbamazepine epoxide

Carbamazepine-10,11-epoxide

Carbamazepine10,11-Epoxide

6H-Dibenz[b,f]oxireno[d]azepine-6-carboxamide,1a,10b-dihydro-